<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/113DAE6A-FCEC-4797-8FCF-6A02C4C26200"><gtr:id>113DAE6A-FCEC-4797-8FCF-6A02C4C26200</gtr:id><gtr:name>AdProTec</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F8ECC47E-FF10-432B-A5B1-38D2BD36EEF4"><gtr:id>F8ECC47E-FF10-432B-A5B1-38D2BD36EEF4</gtr:id><gtr:name>Great North Children's Hospital (GNCH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7C3729AA-933E-4E5E-A502-0DFA7E6E98AD"><gtr:id>7C3729AA-933E-4E5E-A502-0DFA7E6E98AD</gtr:id><gtr:name>Alexion Pharmaceuticals</gtr:name><gtr:address><gtr:line1>352 Knotter Drive</gtr:line1><gtr:postCode>CT 06410</gtr:postCode><gtr:region>North West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3545CDC8-076D-4BD8-B370-8E558F9D46EE"><gtr:id>3545CDC8-076D-4BD8-B370-8E558F9D46EE</gtr:id><gtr:name>Leeds Teaching Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Beckett Street</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS9 7TF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Medicine School Office</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B6FB652A-60C3-48DD-9A33-075D1F759B48"><gtr:id>B6FB652A-60C3-48DD-9A33-075D1F759B48</gtr:id><gtr:name>University of Warwick</gtr:name><gtr:address><gtr:line1>Warwickshire</gtr:line1><gtr:line4>Coventry</gtr:line4><gtr:line5>West Midlands</gtr:line5><gtr:postCode>CV4 7AL</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/113DAE6A-FCEC-4797-8FCF-6A02C4C26200"><gtr:id>113DAE6A-FCEC-4797-8FCF-6A02C4C26200</gtr:id><gtr:name>AdProTec</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA"><gtr:id>1D3C9ADE-5860-4017-88E9-BCDCD95A7CBA</gtr:id><gtr:name>University of Bath</gtr:name><gtr:address><gtr:line1>Claverton Down</gtr:line1><gtr:city>Bath</gtr:city><gtr:postCode>BA2 7AY</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BF06ABFB-9547-484C-84F9-4110ED8759B7"><gtr:id>BF06ABFB-9547-484C-84F9-4110ED8759B7</gtr:id><gtr:name>Manchester University NHS Foundation Trust</gtr:name><gtr:address><gtr:line1>Central Manchester University Hospitals NHS Foundation Trust,Manchester Royal Infirmary,Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9WL</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3992259-C19F-4FE5-9C01-210C819D7264"><gtr:id>C3992259-C19F-4FE5-9C01-210C819D7264</gtr:id><gtr:name>Yale University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F8ECC47E-FF10-432B-A5B1-38D2BD36EEF4"><gtr:id>F8ECC47E-FF10-432B-A5B1-38D2BD36EEF4</gtr:id><gtr:name>Great North Children's Hospital (GNCH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7"><gtr:id>88C5F7F9-8DCC-41C9-BC4F-F37DA01075C7</gtr:id><gtr:name>University of East Anglia</gtr:name><gtr:address><gtr:line1>Earlham Road</gtr:line1><gtr:line4>Norwich</gtr:line4><gtr:line5>Norfolk</gtr:line5><gtr:postCode>NR4 7TJ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7C3729AA-933E-4E5E-A502-0DFA7E6E98AD"><gtr:id>7C3729AA-933E-4E5E-A502-0DFA7E6E98AD</gtr:id><gtr:name>Alexion Pharmaceuticals</gtr:name><gtr:address><gtr:line1>352 Knotter Drive</gtr:line1><gtr:postCode>CT 06410</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3545CDC8-076D-4BD8-B370-8E558F9D46EE"><gtr:id>3545CDC8-076D-4BD8-B370-8E558F9D46EE</gtr:id><gtr:name>Leeds Teaching Hospitals NHS Trust</gtr:name><gtr:address><gtr:line1>Beckett Street</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS9 7TF</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C8C844DC-62CE-4F77-8AF8-CDB32543E6FA"><gtr:id>C8C844DC-62CE-4F77-8AF8-CDB32543E6FA</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:surname>Hayday</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/33315F93-BB00-491D-A280-E191361BD24E"><gtr:id>33315F93-BB00-491D-A280-E191361BD24E</gtr:id><gtr:firstName>Cosimo</gtr:firstName><gtr:surname>De Bari</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/259A9C4C-8DF6-48F9-B626-B414032F4DC8"><gtr:id>259A9C4C-8DF6-48F9-B626-B414032F4DC8</gtr:id><gtr:firstName>Frank</gtr:firstName><gtr:surname>Nestle</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/982456DE-E06B-465F-9F39-CA4B2019B9A7"><gtr:id>982456DE-E06B-465F-9F39-CA4B2019B9A7</gtr:id><gtr:firstName>Reza Sarvghad</gtr:firstName><gtr:surname>Razavi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/893D66CD-2721-4DA1-BC08-7050127B4B3A"><gtr:id>893D66CD-2721-4DA1-BC08-7050127B4B3A</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>H</gtr:otherNames><gtr:surname>Sacks</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D755320B-897A-4664-984C-1480D6978A96"><gtr:id>D755320B-897A-4664-984C-1480D6978A96</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:surname>Lechler</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/954E1719-7EB6-4B83-979B-40E0DCB02AF3"><gtr:id>954E1719-7EB6-4B83-979B-40E0DCB02AF3</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Sharpe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9B069BD-5D15-43B4-B0D6-6A64211DC850"><gtr:id>C9B069BD-5D15-43B4-B0D6-6A64211DC850</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:surname>Solomon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E04275DF-111E-44B5-B7F0-FECA4478B406"><gtr:id>E04275DF-111E-44B5-B7F0-FECA4478B406</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Dorling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600698"><gtr:id>3522978F-1202-4B62-82D9-9661C46F8C3A</gtr:id><gtr:title>Emerging diagnostic and treatment approaches in organ and stem cell transplantation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600698</gtr:grantReference><gtr:abstractText>Replacement of diseased organs and cells by healthy tissue is a dream that has partly been realised through progress in transplantation over the last 50 years. However, for transplantation therapy to achieve greater success and on a wider scale, advance is needed in several directions. These include finding supplementary sources of donor tissues and cells that lend themselves for therapy of a larger number of conditions, such as kidney and liver failure, arthritis, diabetes and tooth loss; and a way of ensuring acceptance of the replacement tissue without the need for lifelong drugs that block the immune system. To accelerate progress, experts in basic biology and transplant medicine at King s College London plan to come together in a joint venture with the Medical Research Council, to form the UK s first MRC Centre for Translation of Research in Transplantation. The Centre s mission is to put research in transplantation on a new trajectory to deliver more rapid and effective modes of diagnosis and treatment. The programme of research will apply extensive knowledge of human immunology, stem cell biology, genomics and imaging to develop new areas that will benefit human health. In collaboration with the King s College Centre of Medical Law and Ethics, the MRC Centre will also play a pivotal role in training and education.</gtr:abstractText><gtr:technicalSummary>The immune system represents a formidable barrier to organ and cell transplantation adding to the problems caused by severe shortage of replacement tissues. We present a co-ordinated and integrated vision for how basic and clinical research can combine at a single centre to provide new diagnostic and therapeutic opportunities that can be applied to the alleviation of human suffering. The premise is that more specific manipulation of the inflammatory and immune systems will increase the number of donor organs that can be used for transplantation, will reduce the number of mid-term graft failures and will lead to minimisation or elimination of pan-immunosuppressive therapies, thus lowering the incidence of related malignancies. The proposed strategies include: (1) development and clinical trial of membrane targeted regulators of the complement and clotting cascades for the pre-treatment of donor organs; (2) investigation and development of clinical-grade cell based therapies to promote long-term graft acceptance without continuous immunosuppressive drugs; (3) development of new imaging methods for visualising and monitoring the activity of innate and adaptive immune systems, initially in pre-clinical models; (4) clinical and experimental evaluation of biomarkers that help to predict and interpret outcomes of transplantation; and (5) strategies for addressing the impact of the immune response in allogeneic stem cell based therapies. Outcome measures will take into account the rates of organ dysfunction due to ischaemia-reperfusion insult and acute rejection crises, annual graft survival rates, indices of chronic rejection, infection rates, clinical tools for measurement of tolerance, specificity and sensitivity of imaging procedures and predictive analysis in large, well-defined patient cohorts. The initial application and exploitation of the research results will take place in the fields of liver, kidney, bone marrow and stem cell-based repair/replacement of tooth and articular cartilage, and later will extend to other organs and tissues. The programme of studies within the Centre will provide a vibrant cross-disciplinary environment in which future leaders of research will acquire essential skills including the confidence to engage public interest in transplantation research and its benefits for patients.</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2095276</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Biochemistry</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>F32514B2-7FDE-469D-89E5-EF008734EE71</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-22</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bath</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biology and Biochemistry</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>1181159B-B1A8-42CB-BA9B-AA340D6F4650</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-13</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leeds Teaching Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical Haematology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>526A82BD-0EA0-4EDF-949D-CDF8CAC09A34</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-23</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Requirement of complement C3 for transplant tolerance induction</gtr:description><gtr:id>4CA28F76-23E2-4321-A342-FD6506696D90</gtr:id><gtr:impact>The initial results showing the requirement for C3 in tolerance to skin grafts was presented at an international meeting.</gtr:impact><gtr:outcomeId>E5078E54AA2-1</gtr:outcomeId><gtr:partnerContribution>Provided a Clinical Fellow with an interest in complement and transplantation. This has enabled a new scientific question to be addressed.</gtr:partnerContribution><gtr:piContribution>Led to the initial observation that C3 deficient mice were resistant to tolerance induction.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great North Children's Hospital (GNCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Pediatric Nephrology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>FEAD4D17-514D-4E26-940F-87C9FA3B6D69</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-6</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>72DE1F3C-98AA-49A1-8D9A-F08120BD8374</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-4</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>B97FE4D7-158C-4E85-B2E6-097CB445EF4A</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-5</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Genetics Unit</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>F48B234E-A8EA-4DE3-BB21-DF5735A8EA4A</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-16</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Molecular and Cell Biology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>27DBD5F8-AA6C-4BD2-A527-E678868D6806</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-18</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lombardi-Nestle</gtr:description><gtr:id>D3DC6F30-AD3D-4438-83E5-95B23EC925B5</gtr:id><gtr:impact>See publications - PubMed ID 22937164 &amp;amp; J.Exp.Med.209(5) 935-945; Ali et al. Plos ONE (In Press)</gtr:impact><gtr:outcomeId>ZEixCsJSFoj-1</gtr:outcomeId><gtr:partnerContribution>establishing in vivo model of human skin transplantation</gtr:partnerContribution><gtr:piContribution>regulatory T cell expertise and knowledge in the mechanisms of tolerance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Sir William Dunn School of Pathology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>61941FB7-8A71-4F6F-BFF3-5E801F6D5ED4</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-19</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>Harvard University</gtr:description><gtr:id>8562BD93-0359-4333-9227-5BE114DB9220</gtr:id><gtr:impact>1. Organising GMEC Genetics Symposium (2009) 2. Organising workshops 3. Putting in two grant applications 4. Partnership with Quest (negotiation stage)</gtr:impact><gtr:outcomeId>CE9D59F4830-1</gtr:outcomeId><gtr:partnerContribution>We have access to confidential information and primer sequences that define potential biomarkers currently under investigation in our Centre as a result. It has facilitated recruitment of a new Professor to the MRC Centre from the USA.</gtr:partnerContribution><gtr:piContribution>We have built a research collaboration on biomarkers in transplantation with Professor Terry Strom, by giving him access to patients and testing his samples in the kidney transplant unit. We have jointly written grant awards (L. Barber and S. Longi) and we have jointly funded a joint postdoctoral researcher to look at tissue stress factors in transplantation. In addition, we have set up teaching sessions to introduce research opportunities from Harvard University and we have set up a major international symposium (GMEC Genetics Symposium, November 2009) which featured his work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine Southampton</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>38300061-76AD-4A5E-A732-19009ABF2989</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-20</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>0072A7B0-5897-40F8-BF43-2C3C26B853E2</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-14</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Ophthalmology UCL</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>3D0BAA22-EED7-49C1-8BD9-AE37D9637BD3</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-7</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Infection, Immunity and Inflammation</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>F39ABA4A-7358-4116-93C4-97CD574F9785</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-17</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Warwick</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Warwick Medical School</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>14598D1D-07C1-46AF-8244-1A19DB21EECA</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-21</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>5EF285A7-E33D-4B41-9122-6324BB0C5673</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-3</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Structural Molecular Biology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>D22302F5-5567-49A1-BA45-E09F41423DB7</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-10</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pharmaceutical Sciences</gtr:department><gtr:description>University of Pittsburgh - Immunology Department</gtr:description><gtr:id>83A89FC2-A35B-4DDB-AD28-3A1F168F83A0</gtr:id><gtr:impact>1. Imperial College PhD award for Chih Che Li 2. Publications: a. Pubmed ID: 19000927 b. Pubmed ID: 18791452</gtr:impact><gtr:outcomeId>84AF4D023C4-1</gtr:outcomeId><gtr:partnerContribution>Contributed one year of work in our laboratory for a self funded PhD student.</gtr:partnerContribution><gtr:piContribution>We provided the expertise, laboratory equipment and facilities and intellectual input into this project. The work was partly funded by NIH grant.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Research Department of Epidemiology and Public Health</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>9182FC0D-F808-4326-B347-5489DB30BE05</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-9</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Alexion Pharmaceuticals</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Alexion Pharmaceuticals</gtr:description><gtr:id>FCE6341A-7E4D-402A-AD96-460016652795</gtr:id><gtr:impact>The therapeutic antibody failed to penetrate into transplanted kidney and therefore helped to define types of injury that would not amenable to this particular therapeutic strategy.</gtr:impact><gtr:outcomeId>C3B90176623-1</gtr:outcomeId><gtr:partnerContribution>Alexion Pharmaveuticals provided Chemicals, Consumables and animals to this study</gtr:partnerContribution><gtr:piContribution>We collaborated on an investigator led pre clinical study to determine the impact of complement inhibitor (anti-C5) on reperfusion injury in native and transplant kidneys.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Complement UK</gtr:description><gtr:id>67BA7AD4-1611-4C51-B526-7A5BE6706A0D</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-11</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AdProTec</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AdProTec, UK</gtr:description><gtr:id>A9414E6A-4914-40E2-9086-40EE17A5A351</gtr:id><gtr:impact>Publications - Pubmed references 14507653 and 16510763 Joint patent application (Case 40336). This is now wholly owned by King's College London. Led to development of PhD project successfully awarded in 2006. Keynote symposium presentations including Presidents Lecture, Transplantation Society for Australia and New Zealand 2007.</gtr:impact><gtr:outcomeId>B033F968172-1</gtr:outcomeId><gtr:partnerContribution>The company provided chemicals and consumables for this study</gtr:partnerContribution><gtr:piContribution>1.Established the rationale of membrane targetting approach to prevent complement injury in donor kidney organs. 2. Enabled pre clinical study in prevention of reperfusion damage. 3. Enabled and led clinical (phase IIa) study to determine safety and feasibility of treating donor organs prior to transplantation.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of East Anglia</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine UEA</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>B8B5914F-B83C-4915-80D0-2B0825623C66</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-12</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust Case Control Consortium 3</gtr:description><gtr:id>93467B45-2100-4D09-B943-753773D9BFAF</gtr:id><gtr:impact>A pilot genome study involving around 600 donor-recipient pairs at Guy's Hospital has been completed. Publication on Complement genes submitted.</gtr:impact><gtr:outcomeId>1488911461E-1</gtr:outcomeId><gtr:partnerContribution>funding and SNP analysis</gtr:partnerContribution><gtr:piContribution>Graham Lord and co-applicants in the MRC Centre put together a transplant GWAS proposal, which led to a network of 22 transplant centres in the UK and Ireland who will contribute donor and recipient DNA.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Infection and Immunity</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>1FBA4514-9BDF-4D9C-83A0-EDBFEAFA8F93</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-1</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Lombardi-Mullen</gtr:description><gtr:id>D3B5B806-3EFF-4591-AFCD-ACB00082C071</gtr:id><gtr:impact>2 publications already in pub med and 3 more in preparation</gtr:impact><gtr:outcomeId>p4FrZKkH8CZ-1</gtr:outcomeId><gtr:partnerContribution>expertise in full body imaging</gtr:partnerContribution><gtr:piContribution>regulatory T cell expertise and models of skin transplantation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Manchester University NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nephrology and Transplantation</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>1335FA93-55C7-44B2-B8E4-012453617D95</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-24</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Yale University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Yale University</gtr:description><gtr:id>3545BA29-4FF5-4403-ABDD-03449785F8B9</gtr:id><gtr:impact>Publication available in e Print. Author Prof Adrian Hayday. Journal of Investigative Dermatology 2009. Study of T cells that promote tissue growth and wound repair.</gtr:impact><gtr:outcomeId>7216E5BB161-1</gtr:outcomeId><gtr:partnerContribution>Development of collaborative programme</gtr:partnerContribution><gtr:piContribution>Development of collaborative research programme</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological Sciences</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>75B440FA-F623-4BE6-8D81-798E97591159</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-15</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>C4764A40-F429-4338-83BD-23083CA48233</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-8</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bristol</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Cellular and Molecular Medicine</gtr:department><gtr:description>Complement UK</gtr:description><gtr:id>7EC665E8-9191-4347-88FA-D93010E372DA</gtr:id><gtr:impact>Alexion funded four year PhD Studentships x 4
First annual conference 2011; repeated 2012, 2013.
Special Editions of the Journal of Immunobiology (November 2012); (2013 in prep)</gtr:impact><gtr:outcomeId>dfjK8MFHQz8-2</gtr:outcomeId><gtr:partnerContribution>The partners consist of over 30 PIs at over 20 Centres in the UK. They have contributed through an Executive Committee to the strategy development and implementation. In particular they have helped run annual events and studentship funding.</gtr:partnerContribution><gtr:piContribution>Initiated formation of Complement UK in conjunction with Prof Paul Morgan (Cardiff University). Developed a research and training strategy.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Ethics Symposium</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>18438586-9611-494A-8BE6-5B6B73B0DBF7</gtr:id><gtr:impact>The MRC Centre for Transplantation held an ethics workshop entitled 'on the possibility of translation'. The workshop was attended by ethicists, lawyers, scientists, social scientists and clinicians.

At the end of the meeting the group made two proposals. First, that a one day seminar be held to address the problem of nomenclature and regulatory processes in the context of translational research. Second, that a Health Services Research Fellow (a post doctoral social scientist) be appointed to address generally how innovative research methods are conceived by patients, clinicians, scientific researchers, and organ donors, and to address more specifically issues relating to biomarker studies and clinical transplantation. This appointment is now underway.</gtr:impact><gtr:outcomeId>CFEAB5C15BD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NICE expert panel</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>77E1D631-4B45-42CA-80BE-74F943092828</gtr:id><gtr:impact>LUTS and incontinence guidelines.

The role of Role of Botulinum Toxin-A was presented to NICE for due consideration</gtr:impact><gtr:outcomeId>bPENtnGPmc1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patients' Association Open Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>FC3EDD09-399D-4A2C-91FB-7ED9946F9189</gtr:id><gtr:impact>Laboratory visit and talk concerning ongoing research.

Articles in National KPA newsletter.</gtr:impact><gtr:outcomeId>95FE00AAE7D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>KPA Open Day - How and why we do research on tolerence in kidney transplant patients</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>3D934A88-27C3-4546-AD71-E39BAC57A35A</gtr:id><gtr:impact>Dr Maria Hernandez-Fuentes explained to patient groups why we do research in biomarkers in tolerence for kidney transplant patients and what are the outcomes so far.

The study was mentioned in the national press when it was published in June and other electronic sources in of general science. The importance was given to the fact that we could be eventually able to identify a small groups of patients that may not need as much immunosuppression as it is used now.</gtr:impact><gtr:outcomeId>51E67D987BC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>KPA Open Day - The RituxiCAN-C4 trial</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>2A2014E9-5144-415E-9A85-FCD32970477F</gtr:id><gtr:impact>Professor Anthony Dorling gave an overview of the problem called chronic rejection - the fact that kidney transplants fail prematurely, and outlined the research ongoing to try and address this problem, focusing on the study he has been running, called 'RituxiCAN-C4'

Professor Dorling supplied a brief overview of the trial for the KPA newsletter, which was published at the end of May. &amp;nbsp;</gtr:impact><gtr:outcomeId>EEB230B764B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>CFF460F2-5581-42FF-A117-FA8161DE939F</gtr:id><gtr:impact>Prof Steven Sacks describes his work on finding an easier way to get the body to accept a new organ on BBC Radio 4.

Publicity for the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>D9085ACDB71</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomic subpopulations and health systems responses</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>497FC7EF-10E9-4F4A-8072-1D3370C60C24</gtr:id><gtr:impact>A workshop to examine developments in genomic subclassification and the impact this is likely to have on health system responses. Emphasis on how advances in genetic immunotyping may change or challenge organ donation and transplantation practice.

Greater involvement and understanding of the Centre's work by academics from allied disciplines..</gtr:impact><gtr:outcomeId>212EAD889C6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The ethics of organ retrieval: goals, rights and responsibilities</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8FA69CCD-D9CD-479F-BDAB-315C1EECB679</gtr:id><gtr:impact>This was a unique forum bringing together clinicians, academic lawyers, ethicists, policy makers, key stakeholders and members of the public, concerned with organ donation and transplantation. The discussion focused on ethical issues regarding organ retrieval and its impact on transplant services and outcome.

Informed policy development on: a. required referral for brainstem death testing and organ donation on the basis of clinical triggers'; b. Donor organ optimisation. Led to a special issue of the Journal Clinical Ethics &amp;quot;&amp;quot;The ethics of organ retrieval' which will examine empirical ethics, law and public policy.</gtr:impact><gtr:outcomeId>13CF6E349D9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC R4</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>91C56CF4-0F58-4BCC-9D86-99791DB46BB5</gtr:id><gtr:impact>Recorded broadcast on national radio on the ethics of transplantation as part of the BBCR4 science series Inside the Ethics Committee</gtr:impact><gtr:outcomeId>nJ34feLtj9H</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Associate Parliamentary Committee for Surgical Services</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F48A81DA-A328-4E5E-9F3B-B2812CA7E8ED</gtr:id><gtr:impact>Advised House of Lords on the need for simulation for patient safety, European Working Time Directive, Emergency Surgery

Awaiting outcomes</gtr:impact><gtr:outcomeId>EbXWZhf7Pk8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patients Association Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>03AEA8A2-9830-44BF-BF90-A49A60D51DB6</gtr:id><gtr:impact>On Saturday 28th February the MRC Centre threw open its doors to the local KPA, their family and friends. Visitors were treated to a tour of the labs, where staff demonstrated some of the current research techniques and highlighted some of the new initiatives.

It was a great opportunity for those affected by kidney disease to learn about the future direction of their treatment. &amp;quot;It is amazing what [they] are doing&amp;quot; said Mr Ron Brooker, one of the visitors. &amp;quot;I enjoyed meeting the people involved...and what wonderful machines!&amp;quot;. The lab staff also appreciated meeting the people who will directly benefit from their work.</gtr:impact><gtr:outcomeId>07CEB87D45D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Extending the Life of the Transplant</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>3FCC51A4-64E6-487E-A3D0-593A7D97E37B</gtr:id><gtr:impact>The meeting will bring members of the public face to face with researchers, clinicians and patients dealing with the early failure of transplants and discuss how scientific advance is envisaged to overcome these challenges. Presentations will be aimed at a lay audience, in particular school children who will engage in ethics debate.

Intended to raise public awareness of the scientific contribution to transplantation and increase interest in the organ donor registry.</gtr:impact><gtr:outcomeId>ABCD1D90EA3</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Away Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>9F5D424D-2904-4CF2-9CDE-DF9EE6E2079B</gtr:id><gtr:impact>Over 70 delegates from across the Centre and beyond enjoyed a full programme of events including presentations from Dr Varuna Aluvihare and Professor Steven Sacks; a series of talks on current areas of clinical translational research and a lively debate on some of the major issues facing the Centre. Issues discussed included defining priority areas for clinical/academic research and the Centre's promotion of clinical engagement. Professor Andrew Bradley from Cambridge University delivered some provocative insights in his keynote speech, outlining possible future challenges to the Centre.

That the away day attracted such a diverse audience only added to its success. Some excellent ideas emerged at the event, such as developing supported mentorship for staff and creating opportunities for clinicians to shadow lab staff and vice versa. Also suggested was a Centre discussion board for staff from all areas to share ideas in an easy to use forum.</gtr:impact><gtr:outcomeId>C97C4691AD7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Away Day</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>C8DBFD40-9B3F-4ECC-BE59-7CB15C1F8598</gtr:id><gtr:impact>A meeting to engage clinicians in the scientific programme of the Centre and vice versa, and to promote patient-involvement in the Centre's mission, through breakout sessions, some of which were patient-led.

A collaborative grant proposal has been submitted to the NIHR; progress with Transplant Biobank across the Centre; KPA involvement in the planning of the Bristish Science Festival; increased coverage in KPA newsletters; started monthly educational sessions with patients.</gtr:impact><gtr:outcomeId>7A3097A653A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GMEC Genetics Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>CE6D1C96-5842-4B61-972B-2F08815A97FF</gtr:id><gtr:impact>The workshop brought together a group of experts and potential collaborators who expressed interest in trying to understand how genetic variation influences the results of transplantation and how this can help to personalise anti-rejection therapy and improve outcomes.

The workshop increased awareness of the need for collaboration between UK centres in achieving the goals. It has also resulted in a newsletter on the GMEC and KCL websites, which raised the profile of the necessary work. The presence of a Nature editor at the meeting also raised the possibility of future dissemination.</gtr:impact><gtr:outcomeId>2E441C25A71</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Session Organiser for BSI 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>71440881-8D01-4D51-8A5F-C50A74A53EC0</gtr:id><gtr:impact>None as yet - Meeting occurring 2-5 December 2013</gtr:impact><gtr:outcomeId>Bi5LqS5quVC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.bsicongress.com/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>KPA Newsletter - The RituxiCAN-C4 trial</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>BE720985-54B6-4B1E-936B-E1E55DAFC9E7</gtr:id><gtr:impact>Following the talk to the KPA, Professor Dorling was requested to provide a brief overview of his clinical research for the KPA newsletter which was published in May 2010

This was distributed across all dialysis and transplant sites for all the renal patients to see.</gtr:impact><gtr:outcomeId>C2ADD12010B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>TIME magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>70A84C6A-3DE4-402B-B4D6-2973D1A90693</gtr:id><gtr:impact>Prof Steven Sacks was interviewd by TIME magazine and his views were incorporated into the article &amp;quot;In Spain, a transplant that rules out rejection&amp;quot; by Claudia Castillo (November 2008)

The MRC Centre for Transplantation has been presented in a wide range of audience in USA.</gtr:impact><gtr:outcomeId>9A6F3D694E9</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>A0C55D20-0F6D-41EE-BDBF-791705E049B5</gtr:id><gtr:impact>Prof Steven Sacks describes his work on finding an easier way to get the body to accept a new organ on BBC Radio 4.

Publicity for the work of the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>4270F550390</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>31D07142-A7F9-4627-B1CC-017E062C8E46</gtr:id><gtr:impact>BBC Radio 4 invited Professor Steven Sacks to talk about a new technique that would extend the life of a kidney transplant significantly.

The story received media attention and was later supported by the successful application of an award to help with first in man clinical trials.</gtr:impact><gtr:outcomeId>tEEMXwZdhdu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PEOPLE Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>C4410B65-16A2-4F59-B6AC-701E3AF082EC</gtr:id><gtr:impact>Article entitled: &amp;quot;Improving transplant sucess&amp;quot;.

Exposure of the MRC Centre and its work to wides community and Health professionals within the Trust.</gtr:impact><gtr:outcomeId>2345B37A07D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patient's Association Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:id>AFC2EF38-5EBA-4332-B48B-11AFB91B226D</gtr:id><gtr:impact>Laboratory visit and talk concerning ongoing research.

Articles in National KPA Newsletter</gtr:impact><gtr:outcomeId>1CCB9DD0CF2</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social Mobility Foundation Inernship programme</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>857001D6-6020-4702-9701-3B653E3C5B90</gtr:id><gtr:impact>The Social Mobility Foundation is organising Internship Programmes every year and the MRC Centre offered to be involved,

quote from one of our interns &amp;quot;I just wanted to say a quick thank you as the internship was very useful as it has undoubtedly heightened my understanding of the career path that I am considering. Not only has it allowed me to expand my knowledge beyond the curriculum but it has also boosted my confidence and interpersonal skills.

Thank you very much for such a great opportunity.&amp;quot;
This student is about to start her final year and pass her A levels and move on to a science higher degree.</gtr:impact><gtr:outcomeId>3349360660D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://www.socialmobility.org.uk/</gtr:url><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Involvement talks- KPA</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>5D856E42-C95E-4AA7-B7B3-1D01D0C111FA</gtr:id><gtr:impact>Monthly meetings between research staff and kidney patients to explain the research that is taking place in the Centre.

Greater patient involvement and understanding of the Centre's work.</gtr:impact><gtr:outcomeId>3DDC0E6F2C8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Kidney Patients Association Board Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B90DE8B1-681E-43CF-848A-F91850D7F556</gtr:id><gtr:impact>Summary of translational research including progress with complement inhibitors and potential therapeutics.

Ongoing funding notably &amp;pound;750K contribution to the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>241791B6F27</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Radio 4 interview</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>B6227BE5-FC53-4CD4-A74C-FA03F265BDB3</gtr:id><gtr:impact>Prof Steven Sacks describes his work on finding an easier way to get the body to accept a new organ at the MRC Centre for Transplantation, on BBC Radio 4.

Gain exposure of the MRC Centre for Transplantation.</gtr:impact><gtr:outcomeId>B7D42AE72E7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>520000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>F3D8AE93-917F-4CE3-95B5-D7CB6D3B7C3E</gtr:id><gtr:outcomeId>D47A6C6AA080</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Public Engagement</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BCA1A782-4EF7-406D-8066-DEE6372DC3F8</gtr:id><gtr:outcomeId>46423FD93C70</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Public Engagement Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>E7735E28-EBF3-4359-881B-3689314D261C</gtr:id><gtr:outcomeId>kTmDxWEoebF0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Guy's &amp;amp; St Thomas' Charity - New Services and Innovations Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Guy?s &amp; St Thomas? Charity</gtr:fundingOrg><gtr:id>2C6771E9-CA35-4F57-9104-1734BA373B33</gtr:id><gtr:outcomeId>0B785351DD40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>203088</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Director's Initiative</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9AA343CE-60DC-48EF-8BAB-EDF07996AC5C</gtr:id><gtr:outcomeId>AanyLEafhoX0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DD942F7A-C833-47AC-AFDE-5DEF36A487C1</gtr:id><gtr:outcomeId>7358415E8440</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Transplant Society Fellowship Award</gtr:description><gtr:end>2009-10-02</gtr:end><gtr:fundingOrg>British Transplantation Society (BTS)</gtr:fundingOrg><gtr:id>3B553AA8-7FDB-481A-898A-16E8C12FFD1F</gtr:id><gtr:outcomeId>FD3EB77D75B0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Senior Investigator award</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>AA0DC1FE-2225-48BA-A6B9-49EA64B750E6</gtr:id><gtr:outcomeId>nbqVX6xSMhL</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>495DC170-D622-42D0-932F-95995E4D37B6</gtr:id><gtr:outcomeId>DC3113112640</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary award</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>FFFCE7EF-CDA3-4936-AF6C-C6223AF34471</gtr:id><gtr:outcomeId>aEyU1rfdtft</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1727417</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Developmental Clinical Study</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A0C2ADA5-1FC0-43FC-89CD-FF3286DC9306</gtr:id><gtr:outcomeId>dMPWsdPbFUQ0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>977000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equipment Grant</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>2BA9A03B-B40D-4161-98ED-2FBDDF85E6C9</gtr:id><gtr:outcomeId>337EC180E140</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>51BCC7F0-8FA1-4004-B700-22BA63B01AC0</gtr:id><gtr:outcomeId>640F843BDAE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5369000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Comprehensive Biomedical Research Centre, Guy's and St Thomas</gtr:department><gtr:description>NIHR Biomedical Center Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>C7D83549-AB20-47F4-8F18-EBE0245CDB4B</gtr:id><gtr:outcomeId>60A83DB16D30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Event award</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5E00C28C-7346-4B2B-A2B6-DAB14CF6BEA8</gtr:id><gtr:outcomeId>eA2W72zt7Qw</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centre Grant (Directors Initiative)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9A0F9AF0-3528-4DD4-A2A5-013BE93F587C</gtr:id><gtr:outcomeId>P1BpHPqvEVm0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>222000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>24207E30-A13C-4C4B-B527-2EEB4C1CE335</gtr:id><gtr:outcomeId>20550E1E88C0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Recovery of IP and materials related to membrane-localising (&amp;quot;cytotopic&amp;quot;) technology discovered by our lead protein chemist and head of Protein Therapeutics Laboratory (before joining our Centre).</gtr:description><gtr:grantRef>G0600698</gtr:grantRef><gtr:id>093B7580-5870-441D-AD22-1FAB2ED6D5C8</gtr:id><gtr:impact>Return of the IP will enable new grant proposals and the conduct of a Phase IIB efficacy study in transplant patients.</gtr:impact><gtr:licensed>Commercial In Confidence</gtr:licensed><gtr:outcomeId>7F30F5F7194</gtr:outcomeId><gtr:patentId>US7888318</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Anticomplement Compounds</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>It has been found that linkage of anticoagulant peptides to membrane-localising (&amp;quot;cytotopic&amp;quot;) reagents generates conjugates which are capable of inhibiting thrombin when attached to cell surfaces. This enables organs to be anticoagulated by perfusion ex-vivo prior to transplantation into the recipient. For the first time, it appears to be possible to separate local antithrombotic effects from systemic pharmacological ones using a readily translatable therapeutic agent.</gtr:description><gtr:grantRef>G0600698</gtr:grantRef><gtr:id>D4D6C7FC-E57A-480C-ACA4-A774B07900E3</gtr:id><gtr:impact>It may be possible to control thrombosis in transplantation (for example, in pancreatic and islet cell transplantation and in the prevention of antibody-mediated acute rejection) using this approach, as shown in early pre-clinical models in rat.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>7CE388A2547</gtr:outcomeId><gtr:patentId>WO2011027175</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Antithrombotic Compounds</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Transplantation Society Living Donor Transplantation Guidelines</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>495A2828-A1E5-4CDC-B97D-3439BA18A39D</gtr:id><gtr:outcomeId>8F9D6366480</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Centre for Transplantation Consultation Response to Academy of Medical Sciences Call for Evidence: Review of the Regulation and Governance of Medical Research</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4F7ABCFA-E68C-4ADA-AB27-54F35AC3D823</gtr:id><gtr:impact>Expected to influence Goverment policy on: having a &amp;quot;single research regulator&amp;quot; with combined responsibility for different aspects of research regulation; the future of the National Research Ethics Service; and the reorganisation of the research regulatory activities of the Human Tissue Authority (which is directly relevant to transplantation).</gtr:impact><gtr:outcomeId>5928A67554C</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Organ Donation Taskforce Ethics Working Group</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>2AFDE78A-CE4E-4B9E-A997-2B30EC3C68B1</gtr:id><gtr:impact>The specific remit of this working group was to consider the potential impact of an 'opt-out' system of organ donation in the UK. The working group reported to the Department of Health.</gtr:impact><gtr:outcomeId>9993EC70DA6</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Technology Strategy Board Assessor Briefing for Healthcare</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0B70D7AF-6226-4096-A40E-1B4D176CA9A7</gtr:id><gtr:outcomeId>545ca1618df9e3.81311432</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC Centre for Transplantation Response to Nuffield Council on Bioethics Consultation paper Giver and Take? Human Bodies in Medicine and Research</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>A068187B-672C-42ED-9E64-C4FDC242D32C</gtr:id><gtr:impact>The evidence gathered in this consultation is likely to affect Government policy on developing a single regulatory authority to consider multiple aspects of medical research. This is likely to have an impact on policy and legislation in organ donation and transplantation.</gtr:impact><gtr:outcomeId>C5585B679A3</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Modified human cytokine designed to generate regioselective immune stimulation within human tumours. Principle source of funding: Prostate Cancer UK/Heathside Fund</gtr:description><gtr:id>336E9764-8E2A-4A82-802A-FB97B1DC02E7</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>S7cHYsZUG8t</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Cytotopic human interleukin 15</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>Membrane - interactive complement inhibitor used by ex vivo perfusion into isolated organ. About to enter definitive Phase II study. Drug manufacture completed to accepted standard. MHRA approved. Patient recruitment imminent. Souce of funding: MRC DCS grant. Recruitment began in July 2015 and 19 patients are now undergoing treatment.</gtr:description><gtr:id>83608E0F-3D73-4993-BB42-12570C2BBAF4</gtr:id><gtr:impact>Validation of the membrane-binding (cytotopic) approach used in Mirococept and the consequent development of this technology as a platform. Large scale manufacture and quality assessment for clinical trial completed. Completed investigators brochure. Ethics approved. MHRA approved. Patient recruitment open.</gtr:impact><gtr:outcomeId>tFCqbjC6TeG</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Empirikal-Mirococept</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>http://www.mykidney.org/Research/ResearchAtGuys.aspx</gtr:url><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>It has been found that linkage of anticoagulant peptides to membrane-localising (&amp;quot;cytotopic&amp;quot;) reagents generates conjugates which are capable of inhibiting thrombin when attached to cell surfaces. This enables organs to be anticoagulated by perfusion ex-vivo prior to transplantation into the recipient. For the first time, it appears to be possible to separate local antithrombotic effects from systemic pharmacological ones using a readily translatable therapeutic agent. It may be possible to control thrombosis in transplantation (for example, in pancreatic and islet cell transplantation and in the prevention of antibody-mediated acute rejection) using this approach.</gtr:description><gtr:id>70A28A47-CB15-4EA2-BFA1-D2662324CE26</gtr:id><gtr:impact>First product of its kind enabling prevention of Thrombosis in an organ transplant without having to anti-coagulate the recipient. Potential use in organs transplanted into pre-sensitised recipients.</gtr:impact><gtr:outcomeId>6B2382568B7</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development_distribution</gtr:status><gtr:title>Antithrombotic agent (PTL004)</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A membrane targeted anti-coagulant for intented use in donor kidneys transplanted into high risk (highly sensitised) recipients. Currently at proof-of-principle stage in rat model. Current funding - MRC Centre Grant Directors Initiative.</gtr:description><gtr:id>05E4ADA9-3072-46DD-B3A9-FD70A2BF5ECD</gtr:id><gtr:impact>Patent application registered.</gtr:impact><gtr:outcomeId>Ly2vea15K3U</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Membrane targeted anti-thrombin PTL006</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Cloning of complement receptor 2 and modification to develop a new imaging tool for detection of complement activation by external body imaging.</gtr:description><gtr:id>F59F4712-BA1D-4C22-910E-99676EC395A4</gtr:id><gtr:impact>Work in progress.</gtr:impact><gtr:outcomeId>04DFAA43EF4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Complement imaging technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Through the Centre collaboration with Genetics, we have established rigorous quantitative expression methods on transplant samples in liver and kidney recipients.</gtr:description><gtr:id>F74F7AD6-54CC-4DC9-9666-2A6C3D4D04EF</gtr:id><gtr:impact>Work in progress</gtr:impact><gtr:outcomeId>33F5C788726</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quantitative PCR</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cloning of complement receptor 2 and modification to develop a new imaging tool for detection of complement activation by external body imaging.</gtr:description><gtr:id>F22DA9B0-0928-4676-B18F-1B9FA72ADE85</gtr:id><gtr:impact>Work in progress.</gtr:impact><gtr:outcomeId>07D09A60764</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Complement imaging technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>1.Refurbishment of office and laboratory space including new human protein therapeutics laboratory to accommodate Centre activities, including new activities. 2.New administrative/research structure for the MRC Centre including Centre Manager, administrative assistant, statistical support and microsurgical team.</gtr:description><gtr:id>AF84B77B-67DB-4473-AC12-1935969DDBCE</gtr:id><gtr:impact>1.Facilitated several major grant awards, as listed. 2.Developed a dedicated Centre website with strongly positive feedback 3.Increased media profile, as listed 4.Dissemination through workshops and meetings as listed and selection for the British Science Festival 2010.</gtr:impact><gtr:outcomeId>7CDD519BE38</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Core administrative and laboratory facilities</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F757AAA8-6C46-481C-BFB8-5F65230F4A5A</gtr:id><gtr:title>A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy.</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/449d0fd41b23ccaad0d1ba2a66472152"><gtr:id>449d0fd41b23ccaad0d1ba2a66472152</gtr:id><gtr:otherNames>Khan MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1368-5031</gtr:issn><gtr:outcomeId>pm_13110_20_22507234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31F66612-967E-408C-87E0-56727E800CBF</gtr:id><gtr:title>Is it unethical for doctors to encourage a healthy adult to donate a kidney to a stranger?</gtr:title><gtr:parentPublicationTitle>International Association of Bioethics, World Congress of Bioethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5994cfe1fcc6cb53757f531cf754127"><gtr:id>e5994cfe1fcc6cb53757f531cf754127</gtr:id><gtr:otherNames>Cronin Antonia J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>o3bgziXyzGb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D545A0BD-9D5E-40DD-B659-9F79A2CBC808</gtr:id><gtr:title>Recognizing and managing the complications of prostate biopsy.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebe0d2b23ad3eef1824886c6fa703ae8"><gtr:id>ebe0d2b23ad3eef1824886c6fa703ae8</gtr:id><gtr:otherNames>Challacombe B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_21958223</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0A861DB-2467-4CE9-8494-E10762918275</gtr:id><gtr:title>Assessing the cost effectiveness of robotics in urological surgery - a systematic review.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e0b4786411cafcf44ac496e87ec7b61"><gtr:id>6e0b4786411cafcf44ac496e87ec7b61</gtr:id><gtr:otherNames>Ahmed K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22443296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A03DE248-7A37-415B-9C6F-BD69BCAA3C45</gtr:id><gtr:title>Biomarkers of tolerance.</gtr:title><gtr:parentPublicationTitle>Current opinion in organ transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29dcf1b4d5dd496e0c0d7f8aefbe6b29"><gtr:id>29dcf1b4d5dd496e0c0d7f8aefbe6b29</gtr:id><gtr:otherNames>G?kmen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1087-2418</gtr:issn><gtr:outcomeId>5464c536cad7e6.42344548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0877E11-92CC-4693-9E9F-B79D22F715B4</gtr:id><gtr:title>Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/321a1e037f644f93e673029ae0a83321"><gtr:id>321a1e037f644f93e673029ae0a83321</gtr:id><gtr:otherNames>Kinsella J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_21883815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE5129D0-642D-48E2-8808-A4FE29488729</gtr:id><gtr:title>The surgeon as educator: fundamentals of faculty training in surgical specialties.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4565dafaf87d213d5e13e790513349db"><gtr:id>4565dafaf87d213d5e13e790513349db</gtr:id><gtr:otherNames>Khan N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22928668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE55492-38CC-4083-8D8F-88075310B2D1</gtr:id><gtr:title>OnabotulinumtoxinA in refractory neurogenic detrusor overactivity.</gtr:title><gtr:parentPublicationTitle>European urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fe4e6cc0b93eb94ab03f7dbc1deb00c"><gtr:id>2fe4e6cc0b93eb94ab03f7dbc1deb00c</gtr:id><gtr:otherNames>Dasgupta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0302-2838</gtr:issn><gtr:outcomeId>pm_13110_20_21840118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>864B4C17-7A67-46A9-A243-E07D6FE9FC9C</gtr:id><gtr:title>Quality-of-care framework in urological cancers: where do we stand?</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/718fa480857b4e78a15fa5135f9d7f54"><gtr:id>718fa480857b4e78a15fa5135f9d7f54</gtr:id><gtr:otherNames>Wang TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22077852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42420159-B749-4351-81C8-787E16BD2255</gtr:id><gtr:title>Donor specific transplant tolerance is dependent on complement receptors.</gtr:title><gtr:parentPublicationTitle>Transplant international : official journal of the European Society for Organ Transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b45355c9a618881be06116dbdce75346"><gtr:id>b45355c9a618881be06116dbdce75346</gtr:id><gtr:otherNames>Bartel G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0934-0874</gtr:issn><gtr:outcomeId>doi_13110__tri_12006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AD01A7C-E73F-4AFE-830F-D38FC0492E96</gtr:id><gtr:title>Genome-wide sequencing of cellular microRNAs identifies a combinatorial expression signature diagnostic of sepsis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/417d43a7089aa342f399b24e0f14fc1c"><gtr:id>417d43a7089aa342f399b24e0f14fc1c</gtr:id><gtr:otherNames>Ma Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464c5372579b3.31602222</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADF706E4-8FD6-4071-A0E5-E7F15EFEF005</gtr:id><gtr:title>How to develop a simulation programme in urology.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e0b4786411cafcf44ac496e87ec7b61"><gtr:id>6e0b4786411cafcf44ac496e87ec7b61</gtr:id><gtr:otherNames>Ahmed K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_21871051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC116665-3D8F-42CA-B625-B1BDEF870063</gtr:id><gtr:title>Enhanced effect of inhibition of thrombin on endothelium in murine endotoxaemia: specific inhibition of thrombocytopenia.</gtr:title><gtr:parentPublicationTitle>Thrombosis research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ef91a6d242b3418b3065118aa4f2f60"><gtr:id>2ef91a6d242b3418b3065118aa4f2f60</gtr:id><gtr:otherNames>Chen D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0049-3848</gtr:issn><gtr:outcomeId>pm_13695_25_24161661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FE65FBF-116A-4656-9D50-2912E198CF3C</gtr:id><gtr:title>Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d136cb0b10a6c9ffc7a02a0d6f2ffb"><gtr:id>27d136cb0b10a6c9ffc7a02a0d6f2ffb</gtr:id><gtr:otherNames>Hernandez-Fuentes MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>5a995ecad2ff70.89275474</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52AB006A-21F8-4101-BE8C-7058B0433259</gtr:id><gtr:title>Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25befd1fbfccea14e32520047fbe60a7"><gtr:id>25befd1fbfccea14e32520047fbe60a7</gtr:id><gtr:otherNames>Zhu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>pm_13110_20_22107848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6144B410-4752-4DCE-83FD-DFD6619297F0</gtr:id><gtr:title>Decision making in urological surgery.</gtr:title><gtr:parentPublicationTitle>International urology and nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0938c60157f1301ed3eb8e647339c7"><gtr:id>fd0938c60157f1301ed3eb8e647339c7</gtr:id><gtr:otherNames>Abboudi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0301-1623</gtr:issn><gtr:outcomeId>pm_13110_20_22367236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC60583E-2DFD-4E56-94C8-876D6388F43A</gtr:id><gtr:title>Current status of robot-assisted partial nephrectomy.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73d9f58125e05baf61793222584a3e6f"><gtr:id>73d9f58125e05baf61793222584a3e6f</gtr:id><gtr:otherNames>Gohil R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22577985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>010DBAAD-99B6-4ECE-B720-302E82C9F0FA</gtr:id><gtr:title>Overcoming the challenges of robot-assisted radical prostatectomy.</gtr:title><gtr:parentPublicationTitle>Prostate cancer and prostatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf917cd3cc72629f737b6bd1576c655d"><gtr:id>cf917cd3cc72629f737b6bd1576c655d</gtr:id><gtr:otherNames>Goldstraw MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1365-7852</gtr:issn><gtr:outcomeId>pm_13110_20_21844888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0014EA2-3C65-496A-95BF-737865D58248</gtr:id><gtr:title>Neurogenic detrusor overactivity in patients with spinal cord injury: evaluation and management.</gtr:title><gtr:parentPublicationTitle>Current urology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e9f2004e7d87500a4279587b7743a69"><gtr:id>6e9f2004e7d87500a4279587b7743a69</gtr:id><gtr:otherNames>Sahai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1527-2737</gtr:issn><gtr:outcomeId>pm_13110_20_21964989</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>411EB9A4-CE74-4488-9A07-72692E79ABA3</gtr:id><gtr:title>Promoting transplantation tolerance; adoptive regulatory T cell therapy.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8f79b3b082d0af0f2cd8470d59b7efb"><gtr:id>f8f79b3b082d0af0f2cd8470d59b7efb</gtr:id><gtr:otherNames>Safinia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>5464c537002315.55508641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A0F3BFC-D353-488C-9809-32298C9879C5</gtr:id><gtr:title>The innate immune system and transplantation.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f41571013db636d13570fa10eaf335ba"><gtr:id>f41571013db636d13570fa10eaf335ba</gtr:id><gtr:otherNames>Farrar CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_13110_20_24086066</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7445A5E6-47B0-4695-ACD2-14A0B9220428</gtr:id><gtr:title>Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.</gtr:title><gtr:parentPublicationTitle>European urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d3404ddc47160c974dc32ddd7ffd49f"><gtr:id>3d3404ddc47160c974dc32ddd7ffd49f</gtr:id><gtr:otherNames>Dowson C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0302-2838</gtr:issn><gtr:outcomeId>pm_13110_20_22204745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65CB1D60-5431-4F3D-9490-49FA3F02D65D</gtr:id><gtr:title>Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1004a15f9a40807681ada9cd0a0728c1"><gtr:id>1004a15f9a40807681ada9cd0a0728c1</gtr:id><gtr:otherNames>Patel U</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22040349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59F0DEAE-417A-4276-B50A-D5018B6C93B0</gtr:id><gtr:title>Robotic assisted radical cystectomy and urinary diversion.</gtr:title><gtr:parentPublicationTitle>International journal of clinical practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fe4e6cc0b93eb94ab03f7dbc1deb00c"><gtr:id>2fe4e6cc0b93eb94ab03f7dbc1deb00c</gtr:id><gtr:otherNames>Dasgupta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1368-5031</gtr:issn><gtr:outcomeId>pm_13110_20_22698412</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C202700-ADE2-47CE-B05B-73EB89A46FC4</gtr:id><gtr:title>Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f6428f92de0bfb11f802069857dd60ce"><gtr:id>f6428f92de0bfb11f802069857dd60ce</gtr:id><gtr:otherNames>Bacchetta R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5464c53683ecd0.05511210</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0326085C-5973-461E-9FD1-A7406F350753</gtr:id><gtr:title>Learning the lessons from 1000 robot-assisted radical prostatectomy procedures.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2986f38093912d086d7fe8ec16e20d7e"><gtr:id>2986f38093912d086d7fe8ec16e20d7e</gtr:id><gtr:otherNames>Kirby R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_23107391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECBCA369-E620-49D7-A3BD-D7E0C1AD2528</gtr:id><gtr:title>CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43405bdee47846dd21c53267cfab3fd4"><gtr:id>43405bdee47846dd21c53267cfab3fd4</gtr:id><gtr:otherNames>Yamamoto H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13110_20_23071686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0EDE87D-81A1-4EAF-B6B1-736983417DB1</gtr:id><gtr:title>Focal HIFU for prostate cancer.</gtr:title><gtr:parentPublicationTitle>The Lancet. Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebe0d2b23ad3eef1824886c6fa703ae8"><gtr:id>ebe0d2b23ad3eef1824886c6fa703ae8</gtr:id><gtr:otherNames>Challacombe B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-2045</gtr:issn><gtr:outcomeId>pm_13110_20_22748266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D43BCAC2-B750-4CB3-ACAE-45854C9C4578</gtr:id><gtr:title>Urology training: past, present and future.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73d9f58125e05baf61793222584a3e6f"><gtr:id>73d9f58125e05baf61793222584a3e6f</gtr:id><gtr:otherNames>Gohil R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22035251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA0C2ABB-8B23-4A40-9D6F-A53077435C40</gtr:id><gtr:title>Indicators for research performance evaluation: an overview.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28b6c05086685b1ae195244cd718c80b"><gtr:id>28b6c05086685b1ae195244cd718c80b</gtr:id><gtr:otherNames>Froghi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22243665</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA0DEC1F-259E-4FFE-ADD2-1473ECA8A029</gtr:id><gtr:title>How to avoid the 'seven deadly sins of surgery'.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2986f38093912d086d7fe8ec16e20d7e"><gtr:id>2986f38093912d086d7fe8ec16e20d7e</gtr:id><gtr:otherNames>Kirby R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22142217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4B22754-28A5-4E11-966A-13277D2A052E</gtr:id><gtr:title>Kinematic design considerations for minimally invasive surgical robots: an overview.</gtr:title><gtr:parentPublicationTitle>The international journal of medical robotics + computer assisted surgery : MRCAS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52ea440f77f3d610c23f3d3a53249d31"><gtr:id>52ea440f77f3d610c23f3d3a53249d31</gtr:id><gtr:otherNames>Kuo CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1478-5951</gtr:issn><gtr:outcomeId>pm_13110_20_22228671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7606D3FC-3886-4686-A47C-4E3A6FC310EC</gtr:id><gtr:title>Urology apps: a review of all apps available for urologists.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d489475faadf25435b817ab4150082a1"><gtr:id>d489475faadf25435b817ab4150082a1</gtr:id><gtr:otherNames>Makanjuola JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22578054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7BD4CCE-2F3F-4856-A73D-59FD18B6958A</gtr:id><gtr:title>Immunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47865decb529fbec9baede373b750846"><gtr:id>47865decb529fbec9baede373b750846</gtr:id><gtr:otherNames>Qian F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13110_20_22675476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D52EAB48-EA1A-44E8-A2DD-A3180A1B1FD7</gtr:id><gtr:title>Oncological outcomes of robot-assisted radical cystectomy.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ac1552d8b047f8aa6d260805bf1c7cf"><gtr:id>5ac1552d8b047f8aa6d260805bf1c7cf</gtr:id><gtr:otherNames>Choudhury SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22044453</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1F8DED0-027A-4E79-99D7-2C33A971CFBD</gtr:id><gtr:title>Finite-element modeling of soft tissue rolling indentation.</gtr:title><gtr:parentPublicationTitle>IEEE transactions on bio-medical engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c11f664eba12d279a05e0a3cb5dff5"><gtr:id>86c11f664eba12d279a05e0a3cb5dff5</gtr:id><gtr:otherNames>Sangpradit K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0018-9294</gtr:issn><gtr:outcomeId>pm_13110_20_21257372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F49D8A4-C499-4262-825F-D7596E619E30</gtr:id><gtr:title>Prostate cancer treatment: the times they are a' changin'.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2986f38093912d086d7fe8ec16e20d7e"><gtr:id>2986f38093912d086d7fe8ec16e20d7e</gtr:id><gtr:otherNames>Kirby R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22937730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6A69A58-E275-4FA2-9F31-2CC83C4FE255</gtr:id><gtr:title>The importance of obtaining truly consensual informed consent.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2986f38093912d086d7fe8ec16e20d7e"><gtr:id>2986f38093912d086d7fe8ec16e20d7e</gtr:id><gtr:otherNames>Kirby R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22520177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E67C38-31D7-4649-AC9C-78B8B524FE3F</gtr:id><gtr:title>[Re(CO)(3)](+) labelling of a novel cysteine/hexahistidine tag: insights into binding mode by liquid chromatography-mass spectrometry.</gtr:title><gtr:parentPublicationTitle>Journal of inorganic biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f831dfb7ef4f512f9897adcb52a97ab2"><gtr:id>f831dfb7ef4f512f9897adcb52a97ab2</gtr:id><gtr:otherNames>Tavar? R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0162-0134</gtr:issn><gtr:outcomeId>pm_13110_20_22687562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AE1CCA2-4FFE-411E-80D9-97ECD2BBB2D1</gtr:id><gtr:title>National Electrical Manufacturers Association NU-4 performance evaluation of the PET component of the NanoPET/CT preclinical PET/CT scanner.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3560639b065b63a76e1c9057b6292f20"><gtr:id>3560639b065b63a76e1c9057b6292f20</gtr:id><gtr:otherNames>Szanda I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>pm_13110_20_21969357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA08DCE6-EACF-409B-8D86-C3938CF1FA6E</gtr:id><gtr:title>Volume matters: bladder injections of botulinum toxin type A.</gtr:title><gtr:parentPublicationTitle>European urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fe4e6cc0b93eb94ab03f7dbc1deb00c"><gtr:id>2fe4e6cc0b93eb94ab03f7dbc1deb00c</gtr:id><gtr:otherNames>Dasgupta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0302-2838</gtr:issn><gtr:outcomeId>pm_13110_20_22386724</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5CABFAF-6C0C-4E92-BF99-57834CF90A03</gtr:id><gtr:title>C1 esterase inhibitor reduces lower extremity ischemia/reperfusion injury and associated lung damage.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9fbde246de427536ea9e3f889d2a2937"><gtr:id>9fbde246de427536ea9e3f889d2a2937</gtr:id><gtr:otherNames>Duehrkop C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13110_20_23991040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1F4B815-80B6-45E1-B819-236849511738</gtr:id><gtr:title>Face, content and construct validity of a virtual reality simulator for robotic surgery (SEP Robot).</gtr:title><gtr:parentPublicationTitle>Annals of the Royal College of Surgeons of England</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35ddb951832654e3dd5ef1d18bd60782"><gtr:id>35ddb951832654e3dd5ef1d18bd60782</gtr:id><gtr:otherNames>Gavazzi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0035-8843</gtr:issn><gtr:outcomeId>pm_13110_20_22041146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>948AFA39-E7F6-4DB1-9256-9D4C5BA6CBE4</gtr:id><gtr:title>Current status of validation for robotic surgery simulators - a systematic review.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd0938c60157f1301ed3eb8e647339c7"><gtr:id>fd0938c60157f1301ed3eb8e647339c7</gtr:id><gtr:otherNames>Abboudi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22672340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9D052C1-9470-464D-B2E5-6D790013E612</gtr:id><gtr:title>Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/243fe4d0f38d033944707f60bc39af22"><gtr:id>243fe4d0f38d033944707f60bc39af22</gtr:id><gtr:otherNames>O'Neill AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>pm_13110_20_23181380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3440D78-0936-44BE-8966-0F5C4E1FC7EA</gtr:id><gtr:title>Overactive bladder and sexual function: a nightmare couple.</gtr:title><gtr:parentPublicationTitle>BJU international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4cd872d14245edc29df28c4d6defa6c"><gtr:id>a4cd872d14245edc29df28c4d6defa6c</gtr:id><gtr:otherNames>Proietti S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-4096</gtr:issn><gtr:outcomeId>pm_13110_20_22882299</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80ED4439-0973-4D09-A29E-1A8DD621EEA1</gtr:id><gtr:title>The role of complement in the early immune response to transplantation.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff9ec214617661fdfb7e5229c6dcdcbf"><gtr:id>ff9ec214617661fdfb7e5229c6dcdcbf</gtr:id><gtr:otherNames>Sacks SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>pm_13110_20_22627861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62C29080-1A04-4246-97EA-8D869BBC3A45</gtr:id><gtr:title>Incontinence: should we inject the trigone during botulinum toxin injection?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Urology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e9f2004e7d87500a4279587b7743a69"><gtr:id>6e9f2004e7d87500a4279587b7743a69</gtr:id><gtr:otherNames>Sahai A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1759-4812</gtr:issn><gtr:outcomeId>pm_13110_20_22249191</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600698</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>70</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>5</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>